Topic: Focus Diagnostics Inc.
Quest Diagnostics (NYSE: DGX), a provider of diagnostic testing services based in Madison, New Jersey, announced Wednesday that the U.S. Food and...
CHICAGO (Reuters) - Quest Diagnostics Inc has developed the first commercially available test to identify U.S. patients infected with the new H1N1 flu virus, the medical testing provider said on Tuesday.Quest said its Focus Diagnostics infectious disease reference laboratory validated the ...